Invention Grant
- Patent Title: Biomarkers predictive of anti-immune checkpoint response
-
Application No.: US16475577Application Date: 2018-01-09
-
Publication No.: US11377697B2Publication Date: 2022-07-05
- Inventor: Eliezer Van Allen , Diana Miao
- Applicant: Dana-Farber Cancer Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Foley Hoag LLP
- International Application: PCT/US2018/012936 WO 20180109
- International Announcement: WO2018/132369 WO 20180719
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; G01N33/50 ; G01N33/574
Abstract:
The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
Public/Granted literature
- US20190338370A1 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE Public/Granted day:2019-11-07
Information query
IPC分类:
